The UK has developed three new “model agreement” templates to help reduce the time, cost and resources for all parties involved with setting up commercially-sponsored studies in National Health Service (NHS)/Health and Social Care (HSC) hospitals.
New UK Model Agreements To Streamline Clinical Research
Efforts are on to reduce the time it takes to set up commercial studies in UK hospitals.
More from United Kingdom
• By
Study sponsors looking for guidance on how the simplified informed consent provisions will be implemented under the new UK clinical trials legislation will have to wait longer. The Health Research Authority is looking at what safeguards are needed to address the “range of concerns” stakeholders had regarding its initial proposal.
• By
A first-of-its-kind review of clinical trial applications submitted to the UK medicines regulator, the MHRA, shows there is a concentration of research in certain disease areas and identifies opportunities to enhance the representation of specific patient groups.
• By
Faced with Trump’s hostile tariff moves, the UK aims to speed up clinical trial start times to support its pharma sector and invest £600m in a new health data research service.
• By
While the pharma industry appears to be exempt from US tariffs imposed by President Trump, a member of the UK House of Lords says the details are unknown and warned that uncertainty “leads to less investment” in business as a whole.